Dr Sanjay Popat is a Consultant Thoracic Medical Oncologist at The Royal Marsden and Honorary Clinical Senior Lecturer in the Molecular Genetics and Genomics Group at the National Heart and Lung Institute, Imperial College London.
Dr Popat qualified from Guy’s and St Thomas’ Hospitals in 1994, completed general medical training at the Royal Brompton, and the Hammersmith Hospital, and medical oncology training at the Royal Marsden Hospital. He was awarded a PhD in Molecular Genetics in 2002 and thereafter undertook a post doctoral Clinician Scientist Fellowship, and subsequently a HEFCE Clinical Senior Lectureship. He has published in the fields of molecular genetics, therapeutic biomarkers, and medical oncology. He has been awarded nationally and internationally competitive prizes for his research, in addition to 4 research fellowships.
His research interests include identification of DNA variants that influence thoracic tumour development and their impact on clinical behaviour, the identification of biomarkers predictive of therapeutic effect, as well as the development of novel therapeutic strategies for the treatment of thoracic tumours through clinical trials.
He is Chairman of the British Thoracic Oncology Group (BTOG), and also chairs the Advanced Diseases Sub-group of the UK NCRI Lung Cancer Clinical Studies Group. He is active in the European Organisation for Research and Treatment of Cancer (EORTC) Lung Group, the European Thoracic Oncology Platform (ETOP), and the International Thymic Malignancy Interest Group (ITMIG).